|Articles|December 11, 2020
- Pharmaceutical Executive-12-01-2020
- Volume 40
- Issue 12
Pharmaceutical Executive, December 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
For Investors, ’Tis the Season to be Gratefulover 5 years ago
A ‘Sign’ of the Times: Digital Contract Transformationover 5 years ago
Opening Digital Doors: Remote Selling During COVID-19over 5 years ago
The C-Suite’s Frontline Workers in Digital Changeover 5 years ago
Guiding Advice for Leaders Through COVID and Beyondover 5 years ago
EU Under Pressure to Make Decisions on Data Sharingover 5 years ago
COVID and AMR: Crisis Reframes Antibiotics Fightover 5 years ago
Here’s to Looking AheadAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
4
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
5

